{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:23:53Z","timestamp":1790886233472,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100016242","name":"Boston Scientific Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016242","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016304","name":"Medtronic Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016304","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006520","name":"Edwards Lifesciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006520","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002336","name":"Daiichi Sankyo Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.carrev.2021.08.004","type":"journal-article","created":{"date-parts":[[2021,8,8]],"date-time":"2021-08-08T04:10:45Z","timestamp":1628395845000},"page":"11-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Successfully Managed Access-Site Complication Was Not Associated With Worse Outcome After Percutaneous Transfemoral Transcatheter Aortic Valve Implantation: Up-to-Date Insights From the OCEAN-TAVI Registry"],"prefix":"10.1016","volume":"38","author":[{"given":"Yohsuke","family":"Honda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Yamawaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahide","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Makino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiaki","family":"Yashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Tada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Naganuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Futoshi","family":"Yamanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Mizutani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Tabata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Shirai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Hayashida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2021.08.004_bb0005","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ijcard.2016.06.159","article-title":"Sapien 3 versus Sapien XT prosthetic valves in transcatheter aortic valve implantation: a meta-analysis","volume":"220","author":"Ando","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.carrev.2021.08.004_bb0010","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1016\/j.jcin.2020.07.013","article-title":"Transcatheter aortic valve replacement with balloon-expandable valves: comparison of SAPIEN 3 Ultra versus SAPIEN 3","volume":"13","author":"Rheude","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2021.08.004_bb0015","first-page":"117","article-title":"Vascular access site complications after transfemoral transcatheter aortic valve implantation in the POL-TAVI Registry: surgical versus percutaneous approach","volume":"61","author":"Walas","year":"2020","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"10.1016\/j.carrev.2021.08.004_bb0020","first-page":"325","article-title":"Access site related vascular complications with third generation transcatheter heart valve systems","volume":"97","author":"Ruge","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2021.08.004_bb0025","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/j.jacc.2012.02.022","article-title":"Clinical outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions: a weighted meta-analysis of 3,519 patients from 16 studies","volume":"59","author":"G\u00e9n\u00e9reux","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2021.08.004_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcin.2011.03.019","article-title":"Transfemoral aortic valve implantation new criteria to predict vascular complications","volume":"4","author":"Hayashida","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2021.08.004_bb0035","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.jacc.2012.09.001","article-title":"Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document","volume":"60","author":"Kappetein","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2021.08.004_bb0040","doi-asserted-by":"crossref","first-page":"690","DOI":"10.4244\/EIJV11I6A137","article-title":"Comparison of suture-based vascular closure devices in transfemoral transcatheter aortic valve implantation","volume":"11","author":"Barbanti","year":"2015","journal-title":"EuroIntervention."},{"key":"10.1016\/j.carrev.2021.08.004_bb0045","doi-asserted-by":"crossref","first-page":"928","DOI":"10.4244\/EIJ-D-16-01036","article-title":"Parallel suture technique with ProGlide: a novel method for management of vascular access during transcatheter aortic valve implantation (TAVI)","volume":"13","author":"Ott","year":"2017","journal-title":"EuroIntervention."},{"key":"10.1016\/j.carrev.2021.08.004_bb0050","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.amjcard.2014.09.047","article-title":"Vascular complications after transcatheter aortic valve implantation and their association with mortality reevaluated by the valve academic research consortium definitions","volume":"115","author":"Steinvil","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2021.08.004_bb0055","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.amjcard.2013.08.022","article-title":"Effect of body mass index on 30- and 365-day complication and survival rates of transcatheter aortic valve implantation (from the FRench Aortic National CoreValve and Edwards 2 [FRANCE 2] registry)","volume":"112","author":"Yamamoto","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2021.08.004_bb0060","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1136\/bmj.299.6714.1497","article-title":"Body weight and mortality in middleaged British men: impact of smoking","volume":"299","author":"Wannamethee","year":"1989","journal-title":"Br Med J"},{"key":"10.1016\/j.carrev.2021.08.004_bb0065","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.amjcard.2020.12.089","article-title":"Standardized measurement of femoral artery depth by computed tomography to predict vascular complications after transcather aortic valve implantation","volume":"145","author":"Durand","year":"2021","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2021.08.004_bb0070","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.amjcard.2016.11.009","article-title":"Incidence, predictors, and mid-term outcomes of percutaneous closure failure after transfemoral aortic valve implantation using an expandable sheath (from the Optimized Transcatheter Valvular Intervention [OCEAN-TAVI] registry)","volume":"119","author":"Nara","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2021.08.004_bb0075","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.amjcard.2017.04.050","article-title":"Outcome of stent graft implantation for treatment of access site bleeding after transfemoral transcatheter aortic valve replacement","volume":"120","author":"Segal","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2021.08.004_bb0080","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jvs.2009.03.050","article-title":"Iatrogenic injuries of the common femoral artery (CFA) and external iliac artery (EIA) during endograft placement: an underdiagnosed entity","volume":"50","author":"Hingorani","year":"2009","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.carrev.2021.08.004_bb0085","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.jcin.2017.03.046","article-title":"Stenting or surgery for de novo common femoral artery stenosis","volume":"10","author":"Yann","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2021.08.004_bb0090","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1161\/01.CIR.102.19.2391","article-title":"Ultrasound-guided thrombin injection for the treatment of postcatheterization pseudoaneurysms","volume":"102","author":"La","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2021.08.004_bb0095","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1253\/circj.CJ-14-1119","article-title":"Ultrasound-guided percutaneous thrombin injection for post-catheterization pseudoaneurysm","volume":"79","author":"Kuma","year":"2015","journal-title":"Circ J"},{"key":"10.1016\/j.carrev.2021.08.004_bb0100","doi-asserted-by":"crossref","unstructured":"de Oliveira Leite TF, Bortolini E, Linard B, Boueri BA, Carnevale FC, Nomura CH, et al. Evaluation of morphological and clinical factors related to failure of percutaneous treatment with thrombin injection of femoral pseudoaneurysms from cardiac catheterization. Ann Vasc Surg 2019;59:173\u2013183.","DOI":"10.1016\/j.avsg.2019.01.013"},{"issue":"9","key":"10.1016\/j.carrev.2021.08.004_bb0105","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1016\/j.jcin.2015.12.265","article-title":"Angioseal-assisted closure of iatrogenic refractory femoral arterial pseudoaneurysm: a novel technique","volume":"28","author":"Hadziomerovic","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2021.08.004_bb0110","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/joic.12468","article-title":"The novel echo-guided ProGlide technique during percutaneous transfemoral transcatheter aortic valve implantation","volume":"31","author":"Honda","year":"2018","journal-title":"J Interv Cardil"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838921005704?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838921005704?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:22:18Z","timestamp":1761560538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838921005704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":22,"alternative-id":["S1553838921005704"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2021.08.004","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Successfully Managed Access-Site Complication Was Not Associated With Worse Outcome After Percutaneous Transfemoral Transcatheter Aortic Valve Implantation: Up-to-Date Insights From the OCEAN-TAVI Registry","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2021.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}